Firm Wire items are announcements made by the firms themselves. The desk confirms that the announcement was published and reproduces its factual content. It does not verify the claims in it, and publication is not an endorsement.
Sidley says it is representing GE HealthCare in its $945 million SOFIE acquisition
Sidley said it is representing GE HealthCare in its $945 million acquisition of radiopharmaceutical company SOFIE Biosciences. The firm said the acquisition will broaden GE HealthCare’s U.S. radiopharmaceutical footprint and that Sharon Flanagan and Dan Belke are leading its transaction team.
Key points
- Sidley said SOFIE operates 15 U.S. contract manufacturing sites and one contract development and manufacturing site.Sidley
- The firm said Anna Remis and colleagues are handling technology and life sciences transactions work.Sidley
- Sidley said Vadim Brusser and colleagues are handling antitrust matters.Sidley
- The firm said Christopher Fanelli and colleagues are advising on food, drug and medical device matters.Sidley